Stratasan and Medalogix top Nashville's recent funding news

Nashville-based analytics and cloud computing company Stratasan has secured $26 million in funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced July 10 and led by Fulcrum Equity Partners.

According to its Crunchbase profile, "Stratasan’s software and services provide market intelligence to hospitals and healthcare systems, equipping them to make better decisions and maximize strategic growth. Their proprietary software platform and reality-driven data analysis provide a foundation for strategic growth including: strategic planning, marketing, physician relations, and mergers and acquisitions. This intelligence is delivered via their proprietary platform and their team of seasoned healthcare strategic growth professionals, they call Spark Services."

The nine-year-old company has raised two previous funding rounds, including a $750,000 seed round in 2012.

Over the past year, three Nashville-based data and analytics companies have secured venture funding, totaling $26 million in new investment to the local industry.

In other local funding news, analytics and information services company Medalogix announced a corporate round on June 25, financed by Encompass Health Corp..

According to Crunchbase, "Medalogix is a health data analytics firm that specializes in the accurate assessment of readmission risk of patients in home health or skilled nursing facilities. Our clients receive daily risk analysis in order that they may make better clinical resource deployment decisions with the end goal being to reduce the rate of rehospitalization among their patients. Early adopters of our service have enjoyed a significant drop in readmission."

Founded in 2009, the company has raised two previous rounds, including a $5 million Series A round in 2014.

This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.